Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bushen Huatan Decoction for insulin-resistant polycystic ovary syndrome
ChiCTR2100053358Phase 4Recruiting
- Sponsor
- Zhangjiagang Hospital of Traditional Chinese Medicine
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Bushen Huatan Decoction and metformin in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Zhangjiagang Hospital of Traditional Chinese Medicine. Primary endpoints: Homeostatic model assessment of insulin resistance, Oral glucose tolerance test and 1 more. Started Jan 2022; status: recruiting.
02
Drugs
Bushen Huatan Decoctionmetformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2100053358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053358.